Artificial Intelligence Blogs
11|06|26
ChatGPT Ads: October 2026 Update and Implications
The advertising landscape in generative AI is moving quickly, and pharma marketers should be paying attention. Since ChatGPT Ads launched in February 2026, OpenAI has rapidly expanded the program to more than 60 countries. While branded prescription drug promotion remains prohibited, recent policy changes have introduced a case-by-case review pathway for select U.S. health categories, including unbranded disease awareness.
10|21|26
Rethinking Commercial Pharma in the Age of AI
Where is AI creating meaningful value in commercial pharma today, and where are expectations still ahead of reality? That question was at the center of Where AI is (and isn't) Changing Commercial Work, the second installment of MATTER's AI in Commercial Pharma series. Faruk Capan, Founder of our agency and Chief Innovation Officer at EVERSANA, joined leaders from Sanofi and Lundbeck to explore how organizations are approaching AI, the challenges impacting adoption and how commercial models could evolve in the years ahead.
09|02|26
Beyond AI-Enabled: Why a New Partner Model Is Vital for Pharmaceutical Marketing in Europe
European pharmaceutical marketers are navigating a uniquely complex landscape, balancing diverse healthcare systems, regulatory environments and market-specific needs. As AI continues to transform commercialization, the conversation must move beyond efficiency gains and automation toward a more fundamental question: what should the future client-agency partnership look like? In this POV, Michael Le Brocq, Global Head of […]
06|23|26
Navigating the New Era of Pharma Search with Google AI Overviews
As Google AI Overviews increasingly become the front door for pharmaceutical discovery, life science brands must adapt their strategies to maintain visibility in a changing search landscape. Josie Black, Head of SEO and GEO, explored this rapid shift to AI-powered, synthesized answers in discussion with pharmaphorum.
05|21|26
Pharma’s AI Influencer Future Depends on One Question: Why Would Anyone Care?
In a new article published on Med Ad News (Pharma Live), Chief Creative Officer Susan Perlbachs explores what recent consumer backlash to AI influencers reveals about the future of influence in healthcare. The takeaway isn’t that audiences reject AI, but that they reject anything that lacks perspective, purpose, or genuine human value.
05|11|26
What Adobe Summit 2026 Signals for Pharma Marketing
Adobe Summit 2026 highlighted a major shift in AI, uncovering new implications for how marketing gets done in pharma. Our latest POV from our team that attended this year’s summit explores what this shift means and how pharma marketers can start preparing for what’s next. Readers will gain insight into: Download the POV to learn more.
04|08|26
The Fourth Hurdle: In the Search for Truth, Will an Algorithm Find Your Drug?
Launch success once depended on approval, access, and adoption, but today, algorithms have become the new gatekeepers. As the patient journey becomes a data journey, this POV, authored by Barry Vucsko, SVP, Strategic Development, examines what it means for marketers when machines decide what evidence rises to the top.
12|29|25
AI’s Next Big Move: Why Pharma Marketers Should Pay Attention
Artificial intelligence is changing the way people interact online, and the pace of innovation is accelerating. Just a few years ago, generative AI was a novelty. Today, platforms such as ChatGPT have become essential tools for millions, shaping how information is shared and decisions are made. At EVERSANA INTOUCH, we’re closely monitoring the next phase […]
12|17|25
Cut Through the Noise: Creative Strategy in the Age of AI
In a recent webinar, hosted by DTC Perspectives, Dan Gandor, EVP, Head of Omnichannel & Digital Transformation and John Kenny, Chief Strategy Officer joined Richard Palizzolo, Executive Director, CX & Advanced Commercial Capabilities at Sobi to explore the evolving landscape of creative strategy in the age of AI.
11|13|25
Beyond Clicks: How AI Is Rewriting Pharma’s Content Playbook
The way healthcare professionals and patients discover information is changing – and changing fast. In a recent article for Med Ad News, Dan Gandor explores why the old “search, click, visit” model no longer hits the right notes and how pharma marketers must adapt to stay in tune.